Ayala Pharmaceuticals Inc (ADXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
10-2009 | 07-2009 | 04-2009 | 01-2009 | 10-2008 | |
Sales | 0 | -5 | 0 | 0 | 0 |
Gross Profit | N/A | -5 | N/A | N/A | N/A |
Operating Expenses | 0 | 1,462 | 772 | 725 | 0 |
Operating Income | N/A | -1,468 | -772 | -725 | N/A |
Interest Expense | 0 | 375 | 21 | 15 | 0 |
Other Income | 0 | 2,014 | 0 | 0 | 0 |
Pre-tax Income | 0 | 172 | -793 | -740 | 0 |
Income Tax | N/A | N/A | N/A | -922 | N/A |
Net Income Continuous | N/A | 172 | -793 | 182 | N/A |
Net Income | $N/A | $172 | $-793 | $182 | $N/A |
EPS Basic Total Ops | N/A | 0.00 | -0.01 | 0.00 | N/A |
EPS Basic Continuous Ops | N/A | 0.00 | -0.01 | 0.00 | N/A |
EPS Diluted Total Ops | N/A | 0.00 | -0.01 | 0.00 | N/A |
EPS Diluted Continuous Ops | N/A | 0.00 | -0.01 | 0.00 | N/A |
EBITDA(a) | $N/A | $-1,402 | $-745 | $-698 | $N/A |